Selected research
Industry Research
Activin Receptor Type 1 Industry Research Report 2026
Market perspective
The global Activin Receptor Type 1 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Activin Receptor Type 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Activin Receptor Type 1 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Activin Receptor Type 1 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Activin Receptor Type 1 include Tolero Pharmaceuticals Inc, Oncodesign SA, La Jolla Pharmaceutical Company, Daiichi Sankyo Company Ltd and Blueprint Medicines Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Activin Receptor Type 1 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Activin Receptor Type 1 Market by Company
Tolero Pharmaceuticals Inc
Oncodesign SA
La Jolla Pharmaceutical Company
Daiichi Sankyo Company Ltd
Blueprint Medicines Corp
Activin Receptor Type 1 Segment by Type
LJPC-6417
Dipyridamole
TP-0184
Others
Activin Receptor Type 1 Segment by Application
Alport Syndrome
Kidney Fibrosis
Chronic Kidney Disease
Obesity
Others
Activin Receptor Type 1 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Activin Receptor Type 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Activin Receptor Type 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Activin Receptor Type 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Activin Receptor Type 1 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Activin Receptor Type 1 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Activin Receptor Type 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- LJPC-6417
- Dipyridamole
- TP-0184
- Others
Applications
- Alport Syndrome
- Kidney Fibrosis
- Chronic Kidney Disease
- Obesity
- Others
Companies covered
- Tolero Pharmaceuticals Inc
- Oncodesign SA
- La Jolla Pharmaceutical Company
- Daiichi Sankyo Company Ltd
- Blueprint Medicines Corp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Activin Receptor Type 1 Market Size (2021-2032)
- 2.2.2 Global Activin Receptor Type 1 Sales (2021-2032)
- 2.2.3 Global Activin Receptor Type 1 Market Average Price (2021-2032)
- 2.3 Activin Receptor Type 1 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 LJPC-6417
- 2.3.3 Dipyridamole
- 2.3.4 TP-0184
- 2.3.5 Others
- 2.4 Activin Receptor Type 1 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Alport Syndrome
- 2.4.3 Kidney Fibrosis
- 2.4.4 Chronic Kidney Disease
- 2.4.5 Obesity
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Activin Receptor Type 1 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Activin Receptor Type 1 Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Activin Receptor Type 1 Revenue of Manufacturers (2021-2026)
- 3.4 Global Activin Receptor Type 1 Average Price by Manufacturers (2021-2026)
- 3.5 Global Activin Receptor Type 1 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Activin Receptor Type 1, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Activin Receptor Type 1, Product Type & Application
- 3.8 Global Manufacturers of Activin Receptor Type 1, Established Date
- 3.9 Global Activin Receptor Type 1 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tolero Pharmaceuticals Inc
- 4.1.1 Tolero Pharmaceuticals Inc Company Information
- 4.1.2 Tolero Pharmaceuticals Inc Business Overview
- 4.1.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product Portfolio
- 4.1.5 Tolero Pharmaceuticals Inc Recent Developments
- 4.2 Oncodesign SA
- 4.2.1 Oncodesign SA Company Information
- 4.2.2 Oncodesign SA Business Overview
- 4.2.3 Oncodesign SA Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Oncodesign SA Activin Receptor Type 1 Product Portfolio
- 4.2.5 Oncodesign SA Recent Developments
- 4.3 La Jolla Pharmaceutical Company
- 4.3.1 La Jolla Pharmaceutical Company Company Information
- 4.3.2 La Jolla Pharmaceutical Company Business Overview
- 4.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product Portfolio
- 4.3.5 La Jolla Pharmaceutical Company Recent Developments
- 4.4 Daiichi Sankyo Company Ltd
- 4.4.1 Daiichi Sankyo Company Ltd Company Information
- 4.4.2 Daiichi Sankyo Company Ltd Business Overview
- 4.4.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product Portfolio
- 4.4.5 Daiichi Sankyo Company Ltd Recent Developments
- 4.5 Blueprint Medicines Corp
- 4.5.1 Blueprint Medicines Corp Company Information
- 4.5.2 Blueprint Medicines Corp Business Overview
- 4.5.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Blueprint Medicines Corp Activin Receptor Type 1 Product Portfolio
- 4.5.5 Blueprint Medicines Corp Recent Developments
5 Global Activin Receptor Type 1 Market Scenario by Region
- 5.1 Global Activin Receptor Type 1 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Activin Receptor Type 1 Sales by Region: 2021-2032
- 5.2.1 Global Activin Receptor Type 1 Sales by Region: 2021-2026
- 5.2.2 Global Activin Receptor Type 1 Sales by Region: 2027-2032
- 5.3 Global Activin Receptor Type 1 Revenue by Region: 2021-2032
- 5.3.1 Global Activin Receptor Type 1 Revenue by Region: 2021-2026
- 5.3.2 Global Activin Receptor Type 1 Revenue by Region: 2027-2032
- 5.4 North America Activin Receptor Type 1 Market Facts & Figures by Country
- 5.4.1 North America Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Activin Receptor Type 1 Sales by Country (2021-2032)
- 5.4.3 North America Activin Receptor Type 1 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Activin Receptor Type 1 Market Facts & Figures by Country
- 5.5.1 Europe Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Activin Receptor Type 1 Sales by Country (2021-2032)
- 5.5.3 Europe Activin Receptor Type 1 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Activin Receptor Type 1 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Activin Receptor Type 1 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Activin Receptor Type 1 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Activin Receptor Type 1 Market Facts & Figures by Country
- 5.7.1 South America Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Activin Receptor Type 1 Sales by Country (2021-2032)
- 5.7.3 South America Activin Receptor Type 1 Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Activin Receptor Type 1 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Activin Receptor Type 1 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Activin Receptor Type 1 Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Activin Receptor Type 1 Sales by Type (2021-2032)
- 6.1.1 Global Activin Receptor Type 1 Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Activin Receptor Type 1 Sales Market Share by Type (2021-2032)
- 6.2 Global Activin Receptor Type 1 Revenue by Type (2021-2032)
- 6.2.1 Global Activin Receptor Type 1 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Activin Receptor Type 1 Revenue Market Share by Type (2021-2032)
- 6.3 Global Activin Receptor Type 1 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Activin Receptor Type 1 Sales by Application (2021-2032)
- 7.1.1 Global Activin Receptor Type 1 Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Activin Receptor Type 1 Sales Market Share by Application (2021-2032)
- 7.2 Global Activin Receptor Type 1 Revenue by Application (2021-2032)
- 7.2.1 Global Activin Receptor Type 1 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Activin Receptor Type 1 Revenue Market Share by Application (2021-2032)
- 7.3 Global Activin Receptor Type 1 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Activin Receptor Type 1 Value Chain Analysis
- 8.1.1 Activin Receptor Type 1 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Activin Receptor Type 1 Production Mode & Process
- 8.2 Activin Receptor Type 1 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Activin Receptor Type 1 Distributors
- 8.2.3 Activin Receptor Type 1 Customers
9 Global Activin Receptor Type 1 Analyzing Market Dynamics
- 9.1 Activin Receptor Type 1 Industry Trends
- 9.2 Activin Receptor Type 1 Industry Drivers
- 9.3 Activin Receptor Type 1 Industry Opportunities and Challenges
- 9.4 Activin Receptor Type 1 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst